Driehaus Event Driven Fund (DEVDX)
| Fund Assets | 27.18M |
| Expense Ratio | 1.43% |
| Min. Investment | $10,000 |
| Turnover | 58.00% |
| Dividend (ttm) | 1.86 |
| Dividend Yield | 16.48% |
| Dividend Growth | 1,001.38% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 11.32 |
| YTD Return | -1.33% |
| 1-Year Return | 8.30% |
| 5-Year Return | 9.50% |
| 52-Week Low | 11.26 |
| 52-Week High | 13.38 |
| Beta (5Y) | n/a |
| Holdings | 69 |
| Inception Date | Aug 23, 2013 |
About DEVDX
The Driehaus Event Driven Fund is a multi-asset mutual fund focused on generating positive returns by employing event-driven investment strategies. Its primary objective is to provide superior risk-adjusted performance with low correlation and reduced volatility compared to major market benchmarks, such as the S&P 500 Index. The fund targets opportunities arising from corporate events—such as mergers, acquisitions, restructurings, and other significant transactions—in both U.S. and international equity and debt markets. Managed actively, it aims to capitalize on pricing inefficiencies and disparities related to these corporate activities. The portfolio spans a diverse range of sectors, including healthcare, consumer cyclicals, industrials, financial services, and more, often holding significant positions in cash equivalents to manage risk and liquidity. Launched in 2013, the Driehaus Event Driven Fund is characterized by a relatively low market beta and a history of striving for returns that are less sensitive to broad market movements, making it a noteworthy option within the event-driven investment category.
Performance
DEVDX had a total return of 8.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.27%.
Top 10 Holdings
70.86% of assets| Name | Symbol | Weight |
|---|---|---|
| Northern Institutional Funds - Treasury Portfolio | NTPXX | 32.84% |
| Cash | n/a | 13.07% |
| Crinetics Pharmaceuticals, Inc. | CRNX | 5.32% |
| Xenon Pharmaceuticals Inc. | XENE | 4.84% |
| Septerna, Inc. | SEPN | 2.76% |
| Hillman Solutions Corp. | HLMN | 2.74% |
| Jefferson Capital, Inc. | JCAP | 2.40% |
| K&F Growth Acquisition Corp. II | KFII | 2.39% |
| Bold Eagle Acquisition Corp. | BEAG | 2.33% |
| Oaktree Acquisition Corp. III Life Sciences | OACC | 2.16% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Feb 13, 2026 | $0.20215 | Feb 13, 2026 |
| Dec 18, 2025 | $1.66061 | Dec 18, 2025 |
| Dec 19, 2024 | $0.16913 | Dec 19, 2024 |
| Dec 13, 2023 | $0.55353 | Dec 14, 2023 |
| Dec 14, 2022 | $0.17576 | Dec 14, 2022 |
| Dec 16, 2021 | $1.60958 | Dec 16, 2021 |